Nicola has over 30 years’ global clinical development experience covering all phases in a broad range of therapeutic areas, as well as more specialist cell and gene therapies and medical device development. Prior to joining Biodexa Pharmaceuticals, she has held senior...

Dr de Vries has extensive senior level experience in both the pharmaceutical and biotechnology industry. He is currently CEO and CFO of Pharming group N.V., the Euronext-listed pharmaceutical company. Dr de Vries was previously CEO of both Switzerland-based 4-Antibody...

Dr Turton previously headed Warburg Pincus’ healthcare investing activities in Europe and was a principal at Index Ventures in Geneva. He has over 10 years of experience investing in biopharma companies following a ten-year career in the international pharmaceutical...

Stephen Parker has over 30 years’ experience in leadership roles both in the healthcare industry and in advisory roles. Currently, he is Chairman of Sareum Holdings plc (AIM: SAR) and Drishti Discoveries Ltd., a Non-Executive Director of MGC Pharmaceuticals Ltd...

Vincent has over 17 years of experience within the biotech and CRO industries with a keen interest in Oncology and novel therapeutics. He has a breadth of knowledge within Clinical Operations having worked in various roles and sizes of organisation throughout his...

A chemist by training, Steve has spent more than 30 years in commercially focused roles across multiple sectors of the pharmaceutical industry. Steve has led commercial teams at drug delivery organisations, including Eurand and Bespak, and has held senior roles at...

Fiona is a qualified accountant and has held senior finance positions within the PR and advertising industry, including Group Finance Director of Chime Communications Group. Fiona is a Fellow of the Chartered Association of Certified Accountants.

Dan has 17 years experience in the biotech sector with particular focus on drug delivery and nanotechnologies for oncology. He has managed interdisciplinary R&D programmes across biology, chemistry and engineering. As well as leading Biodexa Pharmaceuticals’...

Dmitry has joined the company in 2021 as a Chief Scientific Officer and is responsible for all R&D activities of Biodexa Pharmaceuticals. He is a medically trained professional with over 17 years of experience in drug and medical devices development. Prior to...

Mr. Stamp is an experienced public company CFO and has held senior positions in a number of significant healthcare companies including as Group Finance Director of Shire plc, Chief Operating Officer of Xanodyne Pharmaceuticals Inc and most recently with AIM quoted...